Period 2 is essential to maintain early endothelial progenitor cell function in vitro and angiogenesis after myocardial infarction in mice

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 5, 2014, Pages 907-918

  Sun, Yuan Yuan ^a   Bai, Wen Wu ^a   Wang, Bo ^a   Lu, Xiao Ting ^a   Xing, Yi Fan ^a   Cheng, Wen ^a   Liu, Xiao Qiong ^a   Zhao, Yu Xia ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial progenitor cells; Myocardial infarction; Period 2

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CIRCADIAN RHYTHM SIGNALING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; PER2 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BINDING; PROTEIN KINASE B;

ANGIOGENESIS; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DEFICIENCY; ENDOTHELIAL PROGENITOR CELL; HEART FUNCTION TEST; MALE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL TRANSPLANTATION; SURVIVAL;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; FORKHEAD TRANSCRIPTION FACTORS; HEART FUNCTION TESTS; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PERIOD CIRCADIAN PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS;

EID: 84900528692     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12241     Document Type: Article

References (53)

1. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999; 85: 221-8.
2. Rae PC, Kelly RD, Egginton S, et al. Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vascular Cell. 2011; 3: 11.
3. Takahashi T, Kalka C, Masuda H, et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5: 434-8.
4. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow derived endothelial progenitor cells. Circulation. 2002; 105: 3017-24.
5. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7.
6. Chironi G, Walch L, Pernollet MG, et al. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis. 2007; 191: 115-20.
7. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353: 999-1007.
8. Rajasingh J, Thangavel J, Siddiqui MR, et al. Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells. PLoS ONE. 2011; 6: e22550.
9. Park JH, Yoon JY, Ko SM, et al. Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction. Exp Mol Med. 2011; 43: 479-85.
10. Iwasaki H, Kawamoto A, Ishikawa M, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006; 113: 1311-25.
11. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008; 45: 514-22.
12. Zheng B, Larkin DW, Albrecht U, et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature. 1999; 400: 169-73.
13. Sun ZS, Albrecht U, Zhuchenko O, et al. RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell. 1997; 90: 1003-11.
14. Tsinkalovsky O, Smaaland R, Rosenlund B, et al. Circadian variations in clock gene expression of human bone marrow CD34+ cells. J Biol Rhythms. 2007; 22: 140-50.
15. Tsinkalovsky O, Filipski E, Rosenlund B, et al. Circadian expression of clock genes in purified hematopoietic stem cells is developmentally regulated in mouse bone marrow. Exp Hematol. 2006; 34: 1249-61.
16. Fukuya H, Emoto N, Nonoka H, et al. Circadian expression of clock genes in human peripheral leukocytes. Biochem Biophys Res Commun. 2007; 354: 924-8.
17. Méndez-Ferrer S, Lucas D, Battista M, et al. Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008; 452: 442-7.
18. Wang CY, Wen MS, Wang HW, et al. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation. 2008; 118: 2166-73.
19. Viswambharan H, Carvas JM, Antic V, et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation. 2007; 115: 2188-95.
20. Vukolic A, Antic V, Van Vliet BN, et al. Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms. Am J Physiol Regul Integr Comp Physiol. 2010; 298: R627-4.
21. Voermans C, Kooi ML, Rodenhuis S, et al. In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood. 2001; 97: 799-804.
22. Britten MB, Abomaali ND, Assmus B, et al. Infarct remodeling following intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast enhanced magnetic resonance imaging. Circulation. 2003; 108: 2212-8.
23. Krishnamurthy P, Thal M, Verma S, et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res. 2011; 109: 1280-9.
24. Sumida A, Horiba M, Ishiguro H, et al. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res. 2010; 86: 113-21.
25. Yang Z, Xia WH, Zhang YY, et al. Shear stress-induced activation of Tie2-dependent signaling pathway enhances reendothelialization capacity of early endothelial progenitor cells. J Mol Cell Cardiol. 2012; 52: 1155-63.
26. Zhu JH, Chen JZ, Wang XX, et al. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol. 2006; 40: 648-52.
27. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol. 2008; 45: 530-44.
28. Su B, Peng X, Jiang D, et al. In vitro and in vivo evaluations of nano-hydroxyapatite/polyamide 66/glass fibre (n-HA/PA66/GF) as a novel bioactive bone screw. PLoS ONE. 2013; 8: e68342.
29. Chapuis N, Tamburini J, Cornillet-Lefebvre P, et al. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica. 2010; 95: 415-23.
30. Chen YH, Lin SJ, Lin FY, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 2007; 56: 1559-68.
31. Huang PH, Chen JS, Tsai HY, et al. Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. J Mol Cell Cardiol. 2011; 51: 109-19.
32. Shen L, Liu Q, Ni J, et al. A proteomic investigation into the human cervical cancer cell line HeLa treated with dicitratoytterbium (III) complex. Chem Biol Interact. 2009; 181: 455-62.
33. Ruiter MS, van Golde JM, Schaper NC, et al. Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci (Lond). 2010; 119: 225-38.
34. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 2004; 287: C572-9.
35. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95: 952-8.
36. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci. 2000; 97: 3422-7.
37. Eckle T, Hartmann K, Bonney S, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch critical for myocardial adaptation to ischemia. Nat Med. 2008; 18: 774-82.
38. Gu X, Xing L, Shi G, et al. The circadian mutation PER2S662G is linked to cell cycle progression and tumorigenesis. Cell Death Differ. 2012; 19: 397-405.
39. Heskamp A, Leibinger M, Andreadaki A, et al. CXCL12/SDF-1 facilitates optic nerve regeneration. Neurobiol Dis. 2013; 55: 76-86.
40. Peng Y, Huang S, Wu Y, et al. Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells Dev. 2013; 22: 3236-51.
41. Gensch C, Clever Y, Werner C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis. J Mol Cell Cardiol. 2007; 42: 670-7.
42. Foukas LC, Claret M, Pearce W, et al. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature. 2006; 441: 366-70.
43. Knight ZA, Gonzalez B, Feldman ME, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006; 125: 733-47.
44. Zhao JJ, Cheng H, Jia S, et al. The p110alpha isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc Natl Acad Sci. 2006; 103: 16296-300.
45. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96: 857-68.
46. Sanjeev S, Natarajan B, Melissa A, et al. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis. 2013; doi: 10.1093/carcin/bgt316 [Epub ahead of print].
47. Carvas JM, Vukolic A, Yepuri G, et al. Period2 gene mutant mice show compromised insulin-mediated endothelial nitric oxide release and altered glucose homeostasis. Front Physiol. 2012; 3: 337.
48. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci. 2001; 938: 83-95.
49. Rolland-Turner M, Goretti E, Bousquenaud M, et al. Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150. PLoS ONE. 2013; 8: e54135.
50. Jujo K, Hamada H, Iwakura A, et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci. 2010; 107: 11008-13.
51. Walter DH, Haendeler J, Reinhold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res. 2005; 97: 1142-51.
52. Caiado F, Dias S. Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair. 2012; 5: 4.
53. Ladhoff J, Fleischer B, Hara Y, et al. Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res. 2010; 88: 121-9.